Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Apellis Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
APLS
Nasdaq
2830
apellis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Apellis Pharmaceuticals, Inc.
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
- May 7th, 2026 4:01 pm
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics
- May 7th, 2026 2:00 pm
Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates
- May 7th, 2026 1:25 pm
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?
- May 1st, 2026 8:00 am
Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Should You Buy?
- Apr 29th, 2026 8:00 am
Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?
- Apr 24th, 2026 7:04 am
OCGN's Gene-Agnostic Strategy Could Reset Retinal Therapy
- Apr 22nd, 2026 10:32 am
Biogen Expands Targeted Therapy Pipeline With Apellis Deal And Alloy Alliance
- Apr 19th, 2026 2:04 pm
Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls
- Apr 14th, 2026 7:53 am
Gilead Expands Oncology Pipeline With $5B Tubulis Deal
- Apr 9th, 2026 10:07 am
Biogen’s Apellis Deal Reshapes Growth Outlook And Valuation Story
- Apr 4th, 2026 12:06 pm
Where the New Houses Are—and What That Says About Growth
- Apr 3rd, 2026 4:10 pm
Here Are Thursday’s Top Wall Street Analyst Research Calls: Akamai Technologies, Astra-Zeneca, Brinker, e.l.f. Beauty, Freeport-McMoran, Vale, Wingstop, Wix.com, and More
- Apr 2nd, 2026 5:45 am
How The Apellis Pharmaceuticals (APLS) Investment Story Is Shifting With New Deals And Analyst Revisions
- Apr 1st, 2026 3:12 pm
Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio
- Apr 1st, 2026 8:07 am
Disney upgraded, Nike downgraded: Wall Street's top analyst calls
- Apr 1st, 2026 7:46 am
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More
- Apr 1st, 2026 6:02 am
Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last?
- Apr 1st, 2026 5:54 am
Biogen uplifts rare disease pipeline with $5.6bn Apellis buyout
- Apr 1st, 2026 5:36 am
Apellis Pharmaceuticals (APLS) Hits 2-Year High on 140% Upside from Biogen Merger
- Apr 1st, 2026 12:48 am
Scroll